Loved The Press Release
I, for one, absolutely loved the Press Release and actually predicted it at 9am this morning (see post #7507). I loved it for several reasons:
Much earlier conclusion of the Pona Trial, which also means we will be getting revenue 6 months, or so, earlier (gotta love that)
The company's confidence that they will be selling two (2) drugs next year.
Real close to a Phase 1 113 trial
If you subtract the ONE TIME charge for the reevaluation of the granted options, they were right on target
We still have 100 Million in the till (which I believe is a bit better than previously guidance)
A strong indication that the succeed trial will show very strong OS figures.
That is what I call a wonderful press release
As usual, JMHO
Barry
